|Articles|April 30, 2021
SEC Separation of ADC Brentuximab Vedotin
Author(s)YMC Europe GmbH
The antibody-drug conjugate was separated from its aggregates and fragments in only one run using a YMC-SEC MAB column and varying mobile phases.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
2
Navigating Adverse Reactions in GLP-1 Treatment
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
